Patent · US Expired

Morpoline-bridged indazole derivatives

US7427617B2 · kind B2 · utility

13Cited by

0References

5Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Achim Feurer · Wilhelmsfeld, DE
Joachim Luithle · Wülfrath, DE
Stephan-Nicholas Wirtz · Wuppertal, DE
Gerhard Konig · Düsseldorf, DE
Johannes-Peter Stasch · Wuppertal, DE
Frank Wunder · Wuppertal, DE
Dieter Lang · Velbert, DE
Elke Stahl · Bensberg, DE
Thomas Schenke · Odenthal, DE
Rudy Schreiber · Menlo Park, US

Key dates

Filing date	Sep 16, 2003
Grant date	Sep 23, 2008
Priority date	—
Expiry date	Aug 19, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel morpholine-bridged indazole derivatives having the formula

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.